BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arias-Stella JA 3rd, Benayed R, Oliva E, Young RH, Hoang LN, Lee CH, Jungbluth AA, Frosina D, Soslow RA, Antonescu CR, Ladanyi M, Chiang S. Novel PLAG1 Gene Rearrangement Distinguishes a Subset of Uterine Myxoid Leiomyosarcoma From Other Uterine Myxoid Mesenchymal Tumors. Am J Surg Pathol 2019;43:382-8. [PMID: 30489320 DOI: 10.1097/PAS.0000000000001196] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Sham S, Hosseini H, Kokabee M, Bendari A, Reham A, Zhong X, Vele O, Villella JA, Unger P, O'leary X, Benhamidam JK. Uterine Leiomyosarcoma with a Novel RAB2A-PLAG1 Gene Fusion.. [DOI: 10.21203/rs.3.rs-2443563/v3] [Reference Citation Analysis]
2 Panagopoulos I, Andersen K, Gorunova L, Lund-Iversen M, Lobmaier I, Micci F, Heim S. Recurrent 8q11-13 Aberrations Leading to PLAG1 Rearrangements, Including Novel Chimeras HNRNPA2B1::PLAG1 and SDCBP::PLAG1, in Lipomatous Tumors. Cancer Genomics Proteomics 2023;20:171-81. [PMID: 36870688 DOI: 10.21873/cgp.20372] [Reference Citation Analysis]
3 Anderson WJ, Dong F, Fletcher CDM, Hirsch MS, Nucci MR. A Clinicopathologic and Molecular Characterization of Uterine Sarcomas Classified as Malignant PEComa. Am J Surg Pathol 2023. [PMID: 36856023 DOI: 10.1097/PAS.0000000000002028] [Reference Citation Analysis]
4 Sham S, Hosseini H, Kokabee M, Bendari A, Reham A, Zhong X, Vele O, Villella JA, Unger P, O'leary X. Uterine Leiomyosarcoma with a Novel RAB2A-PLAG1 Gene Fusion.. [DOI: 10.21203/rs.3.rs-2443563/v2] [Reference Citation Analysis]
5 Sham S, Hosseini H, Kokabee M, Bendari A. Uterine Leiomyosarcoma with a Novel RAB2A-PLAG1 Gene Fusion.. [DOI: 10.21203/rs.3.rs-2443563/v1] [Reference Citation Analysis]
6 Vimercati A, Santarsiero CM, Esposito A, Putino C, Malvasi A, Damiani GR, Laganà AS, Vitagliano A, Marinaccio M, Resta L, Cicinelli E, Cazzato G, Cascardi E, Dellino M. An Extremely Rare Case of Disseminated Peritoneal Leiomyomatosis with a Pelvic Leiomyosarcoma and Omental Metastasis after Laparoscopic Morcellation: Systematic Review of the Literature. Diagnostics (Basel) 2022;12. [PMID: 36553227 DOI: 10.3390/diagnostics12123219] [Reference Citation Analysis]
7 Zhi W, Zheng X, Jin Y. ZC3H7B-BCOR High-Grade Endometrial Stromal Sarcoma with a Mucoid Grossly Feature: A Case Report and Literature Review. IJWH 2022;Volume 14:1701-1708. [DOI: 10.2147/ijwh.s390042] [Reference Citation Analysis]
8 Santisukwongchote S, Thorner PS, Desudchit T, Techavichit P, Jittapiromsak N, Amornfa J, Shuangshoti S, Shuangshoti S, Teerapakpinyo C. Pediatric fibromyxoid tumor with PLAG1 fusion: An emerging entity with a novel intracranial location. Neuropathology 2022. [PMID: 35723650 DOI: 10.1111/neup.12837] [Reference Citation Analysis]
9 Agaimy A, Clarke BA, Kolin DL, Lee CH, Lee JC, McCluggage WG, Pöschke P, Stoehr R, Swanson D, Turashvili G, Beckmann MW, Hartmann A, Antonescu CR, Dickson BC. Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma. Am J Surg Pathol 2022. [PMID: 35575789 DOI: 10.1097/PAS.0000000000001915] [Reference Citation Analysis]
10 Kertowidjojo EC, Bennett JA. Update on Uterine Mesenchymal Neoplasms. Surgical Pathology Clinics 2022. [DOI: 10.1016/j.path.2022.02.008] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Alwaqfi RR, Davick JJ, Bossler AD. EIF4A2 as another novel fusion partner of PLAG1 in lipoblastoma. Human Pathology Reports 2022;27:300582. [DOI: 10.1016/j.hpr.2021.300582] [Reference Citation Analysis]
12 Chiang S. Mesenchymal Tumors, Pathology of the Uterine Corpus. Encyclopedia of Pathology 2022. [DOI: 10.1007/978-3-319-28845-1_5626-1] [Reference Citation Analysis]
13 Thway K. What’s new in adipocytic neoplasia? Histopathology 2022;80:76-97. [DOI: 10.1111/his.14548] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Aubrey C, Mal H, Köbel M, Lee C, Turashvili G, Yip S, Lum A, Nelson G. Protracted clinical course of an AFF1 fusion positive uterine smooth muscle tumor causing diagnostic confusion over a course of 15 years. Gynecologic Oncology Reports 2021;38:100890. [DOI: 10.1016/j.gore.2021.100890] [Reference Citation Analysis]
15 Kikuchi Y, Watabe S, Yamamoto A, Sato K, Fujinuma W, Kawano J, Yuzawa K, Aso T, Eguchi M, Ishida T, Motoi T, Uozaki H. Periosteal Myxoid Leiomyosarcoma Histologically Mimicking Extraskeletal Myxoid Chondrosarcoma: Report of a Case with Histopathological and Cytopathological Comparison with Extraskeletal Myxoid Chondrosarcoma. Acta Cytol 2021;65:541-8. [PMID: 34569497 DOI: 10.1159/000518004] [Reference Citation Analysis]
16 Panagopoulos I, Heim S. Interstitial Deletions Generating Fusion Genes. Cancer Genomics Proteomics 2021;18:167-96. [PMID: 33893073 DOI: 10.21873/cgp.20251] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Selenica P, Conlon N, Gonzalez C, Frosina D, Jungbluth AA, Beets-Tan RGH, Rao MK, Zhang Y, Benayed R, Ladanyi M, Solit DB, Chiang S, Hyman DM, Hensley ML, Soslow RA, Weigelt B, Murali R. Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic Differentiation. Am J Surg Pathol 2021;45:77-92. [PMID: 32889887 DOI: 10.1097/PAS.0000000000001572] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
18 Weisman P, Wei J, Hui P. Molecular Diagnosis. Practical Gynecologic Pathology 2021. [DOI: 10.1007/978-3-030-68608-6_16] [Reference Citation Analysis]
19 Euscher ED, Buza N, Hui P. Immunohistochemistry. Practical Gynecologic Pathology 2021. [DOI: 10.1007/978-3-030-68608-6_15] [Reference Citation Analysis]
20 Chung CT, Antonescu CR, Dickson BC, Chami R, Marrano P, Fan R, Shago M, Hameed M, Thorner PS. Pediatric fibromyxoid soft tissue tumor with PLAG1 fusion: A novel entity? Genes Chromosomes Cancer 2021;60:263-71. [PMID: 33300192 DOI: 10.1002/gcc.22926] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
21 Panagopoulos I, Gorunova L, Andersen K, Lund-Iversen M, Lobmaier I, Micci F, Heim S. NDRG1-PLAG1 and TRPS1-PLAG1 Fusion Genes in Chondroid Syringoma. Cancer Genomics Proteomics 2020;17:237-48. [PMID: 32345665 DOI: 10.21873/cgp.20184] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
22 Williams EA, Sharaf R, Decker B, Werth AJ, Toma H, Montesion M, Sokol ES, Pavlick DC, Shah N, Williams KJ, Venstrom JM, Alexander BM, Ross JS, Albacker LA, Lin DI, Ramkissoon SH, Elvin JA. CDKN2C-Null Leiomyosarcoma: A Novel, Genomically Distinct Class of TP53/RB1-Wild-Type Tumor With Frequent CIC Genomic Alterations and 1p/19q-Codeletion. JCO Precis Oncol 2020;4:PO. [PMID: 33015533 DOI: 10.1200/PO.20.00040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
23 Pareja F, Da Cruz Paula A, Gularte-Mérida R, Vahdatinia M, Li A, Geyer FC, da Silva EM, Nanjangud G, Wen HY, Varga Z, Brogi E, Rakha EA, Weigelt B, Reis-Filho JS. Pleomorphic adenomas and mucoepidermoid carcinomas of the breast are underpinned by fusion genes. NPJ Breast Cancer 2020;6:20. [PMID: 32550265 DOI: 10.1038/s41523-020-0164-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
24 Williams EA, Sharaf R, Decker B, Werth AJ, Toma H, Montesion M, Sokol ES, Pavlick DC, Shah N, Venstrom JM, Alexander BM, Ross JS, Albacker LA, Lin DI, Ramkissoon SH, Elvin JA. CDKN2C homozygous loss identifies a distinct subtype of TP53/RB1-wildtype leiomyosarcoma with frequent CIC genomic alterations and 1p/19q-codeletion.. [DOI: 10.1101/2020.03.02.973305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Linos K. Sarcomas. Genomic Medicine 2020. [DOI: 10.1007/978-3-030-22922-1_11] [Reference Citation Analysis]
26 Lax SF. [Mesenchymal and mixed uterine tumors : Current overview and practical aspects]. Pathologe 2019;40:36-45. [PMID: 30694356 DOI: 10.1007/s00292-019-0567-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Fadare O, Roma AA. Mesenchymal and Miscellaneous Neoplasms of the Uterine Corpus. Atlas of Anatomic Pathology 2019. [DOI: 10.1007/978-3-030-17931-1_5] [Reference Citation Analysis]
28 Oliva E, Zaloudek CJ, Soslow RA. Mesenchymal Tumors of the Uterus. Blaustein's Pathology of the Female Genital Tract 2018. [DOI: 10.1007/978-1-4614-3165-7_10-2] [Reference Citation Analysis]